15Feb

Experience vision therapy in virtual reality at the Northwest Congress of Optometry!

The most advanced virtual reality vision care platform is coming to the 2018 Northwest Congress of Optometry!

Read More
15Feb

Vivid Vision Expands into Europe with CE Mark, Asia Next

Vivid Vision, a medical technology company which uses virtual reality head-mounted displays to treat vision disorders, announced it has received CE Mark registration status in the EU. Vivid Vision’s software suite is used for treating binocular vision disorders such as amblyopia, strabismus, and convergence insufficiency. The software and associated hardware is distributed by VISUS GmbH, based in Stuttgart, Germany.

Read More
26Jan

Glaucoma Awareness Month: What's my risk for developing glaucoma?

January is glaucoma awareness month. As an optometric provider, one of the eye diseases that I would see fairly commonly in my practice is glaucoma. Now, I worked in Veterans Affairs hospital, so my patient base just due to age was at a higher risk for this disease. Glaucoma itself is a disorder that can be easily managed if caught early.

Read More
10Jan

Glaucoma Awareness Month: What can I expect in a glaucoma exam?

Glaucoma is a disorder that affects the optic nerve. For the vast majority of cases, glaucoma occurs when the fluid pressure inside of the eye becomes too high. The result is slow, progressive damage to the optic nerve.

Read More
11Oct

Virtual Reality vision therapy is now available to be prescribed for home use

Vivid Vision releases Vivid Vision Home, allowing eye doctors in the US and Canada to prescribe home use of its groundbreaking treatment for amblyopia, strabismus, and convergence insufficiency.

Read More
25Jul

Dr. Alex Talaber from the Boulder Valley Vision Therapy clinic shares her experience treating patients with virtual reality vision therapy tools

A podcast conversation with Dr. Alex Talaber on the current state of vision therapy, her research into human vision and her experiences treating patients with Vivid Vision.

Read More